Weekly Round up with Stuart Cowell

<p><strong>US stock index futures are mildly higher</strong> following yesterday’s session that saw the indexes close with little change. Lingering disappointment over the efficacy of the anti-viral drug Remdesivir remains a headwind, even though the story from yesterday is in dispute. However, equities continue to take solace in a belief that the worst of the pandemic is over and that some regions could begin to gradually reopen their economies soon.</p>
<p><iframe width="696" height="392" data-origwidth="696" data-origheight="392" data-relstop="1" src="https://www.youtube.com/embed/D-EzgN7Eu7Y?enablejsapi=1&autoplay=0&cc_load_policy=0&iv_load_policy=1&loop=0&modestbranding=1&rel=0&fs=1&playsinline=0&autohide=2&theme=dark&color=red&controls=1&" title="YouTube player" allow="autoplay; encrypted-media" allowfullscreen data-no-lazy="1" data-skipgform_ajax_framebjll=""></iframe></p>
<p><strong>Click </strong><a href="https://www.hotforex.com/en/trading-tools/economic-calendar.html"><strong>here</strong></a><strong> to access the HotForex Economic Calendar</strong></p>
<p><strong>Stuart Cowell</strong></p>
<p><strong>Head Market Analyst</strong></p>
<p><strong>Disclaimer: </strong>This material is provided as a general marketing communication for information purposes only and does not constitute an independent investment research. Nothing in this communication contains, or should be considered as containing, an investment advice or an investment recommendation or a solicitation for the purpose of buying or selling of any financial instrument. All information provided is gathered from reputable sources and any information containing an indication of past performance is not a guarantee or reliable indicator of future performance. Users acknowledge that any investment in Leveraged Products is characterized by a certain degree of uncertainty and that any investment of this nature involves a high level of risk for which the users are solely responsible and liable. We assume no liability for any loss arising from any investment made based on the information provided in this communication. This communication must not be reproduced or further distributed without our prior written permission.</p>